Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, +69

Nature Biotechnology

Viral DiagnosticsCovid-19Diagnostic TestCovid-19 PandemicSerologic Testing +5

Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis

James Lee, Sadaf Mehdizadeh, Jennifer Smith, +5

Science Immunology

Test performance evaluation of SARS-CoV-2 serological assays

Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, +69

Obesity alters pathology and treatment response in inflammatory disease

Sagar P. Bapat, Caroline Whitty, Cody T. Mowery, +40

Nature

ObesityMetabolic SyndromeInflammationChronic Inflammatory DiseasesAnti-inflammatory +5

The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

Shen Dong, Kamir J. Hiam-Galvez, Cody T. Mowery, +17

JCI Insight

Type 1Cell TherapyDiabetes ManagementAutoimmune DiseaseTreg Populations +13

Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies

Theodore L. Roth, P. Jonathan Li, Franziska Blaeschke, +16

Cell

ImmunologyGenome EngineeringImmunotherapeuticsCell BiologyImmune Cell Therapy +5

XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment

Youjin Lee, Derek Bogdanoff, Yutong Wang, +16

Science Advances

Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression

Cody T. Mowery, Jaime M. Reyes, Lucía Cabal‐Hierro, +16

Cell Reports

Chromatin accessibility promotes hematopoietic and leukemia stem cell activity

Lucía Cabal‐Hierro, Peter van Galen, Miguel A. Prado, +14

Nature Communications

Histone ModificationsChromatinChromatin AccessibilityChromatin OrganizationHematological Malignancy +12

Modular pooled discovery of synthetic knockin sequences to program durable cell therapies

Franziska Blaeschke, Yan Yi Chen, Ryan Apathy, +23

Cell